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Abstract
The c-myc proto-oncogene is induced by mitogens and is a central regulator of cell growth and differentiation. The c-myc
product, Myc, is a transcription factor that binds a multitude of genomic sites, estimated to be over 10–15% of all promoter
regions. Target promoters generally pre-exist in an active or poised chromatin state that is further modified by Myc,
contributing to fine transcriptional regulation (activation or repression) of the afferent gene. Among other mechanisms, Myc
recruits histone acetyl-transferases to target chromatin and locally promotes hyper-acetylation of multiple lysines on
histones H3 and H4, although the identity and combination of the modified lysines is unknown. Whether Myc dynamically
regulates other histone modifications (or marks) at its binding sites also remains to be addressed. Here, we used
quantitative chromatin immunoprecipitation (qChIP) to profile a total of 24 lysine-acetylation and -methylation marks
modulated by Myc at target promoters in a human B-cell line with a regulatable c-myc transgene. Myc binding promoted
acetylation of multiple lysines, primarily of H3K9, H3K14, H3K18, H4K5 and H4K12, but significantly also of H4K8, H4K91 and
H2AK5. Dimethylation of H3K79 was also selectively induced at target promoters. A majority of target promoters showed
co-induction of multiple marks - in various combinations - correlating with recruitment of the two HATs tested (Tip60 and
HBO1), incorporation of the histone variant H2A.Z and transcriptional activation. Based on this and previous findings, we
surmise that Myc recruits the Tip60/p400 complex to achieve a coordinated histone acetylation/exchange reaction at
activated promoters. Our data are also consistent with the additive and redundant role of multiple acetylation events in
transcriptional activation.
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Introduction
The fundamental unit of chromatin is the nucleosome,
consisting of 146bp of DNA wrapped around an octamer of the
core histones, H2A, H2B, H3 and H4 [1,2]. Histones are highly
basic globular proteins, with N-Terminal ‘‘tails’’ which can be
heavily modified by a variety of posttranslational modifications, or
histone marks [3]. Among these marks, some are associated with
active chromatin (euchromatin) and/or gene transcription, such as
trimethylation of histone H3 lysine 4 (H3K4me3), or acetylation of
multiple lysines on histones H3 and H4 (H3ac and H4ac). Others
marks are associated with inactive chromatin (heterochromatin)
and transcriptional repression, such as trimethylation of H3 lysine
9 (H3K9me3) or 27 (H3K27), or of H4 lysine 20 (H4K20me3).
The function of other marks still remains to be understood. A
direct effect of histone modifications on promoter regions is the
creation of a dynamic platform upon which the transcriptional
machinery is recruited and assembled [4]. Based on this evidence,
the ‘‘histone code’’ hypothesis suggests that histone marks offer
binding sites to ‘‘reader’’ and ‘‘effector’’ proteins [5]. Indeed,
many nuclear proteins contain motifs such as Bromodomains or
Royal Family domains, that selectively interact with acetylated or
methylated residues, respectively [6,7]. Histone acetylation is
catalyzed by a variety of histone acetyltransferase complexes
(HATs), which usually target multiple lysine residues [8]. HATs
function enzymatically by transferring an acetyl group from acetyl-
coenzyme A (acetyl-CoA) to the a ˚-amino group of specific lysine
residues [9]. Acetylation, which neutralizes the positive charge of
the lysine side-chain, is thought to weaken histone-DNA or
nucleosome-nucleosome interactions, thereby destabilizing chro-
matin structure and allowing greater accessibility [10]. On this
basis, histone acetylation has also been proposed to act
cumulatively, with the number rather than exact position of the
targeted residues accounting for downstream effects [11]. An
alternative view is that there is specificity in the targeted residues.
In yeast, for example, co-expressed genes, regulated by the same
set of transcription factors acetylate the same lysine residues, which
in turn signal for distinct downstream functions [12].
c-Myc is a transcription factor of the basic helix-loop-helix
leucine zipper (bHLH-LZ) family, which dimerizes with another
bHLH-LZ protein, Max. Myc/Max dimers specifically bind the
DNA sequence CACGTG, a variant of the general CANNTG ‘‘E-
box’’ consensus bound by bHLH proteins [13,14], and activate
transcription via this site [15,16,17]. Medium- and large-scale
screens have revealed that Myc targets at least 10–15% of all
cellular promoters in human cells [18,19,20,21,22]. Studies in
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indicate equally large numbers. Although the exact figure remains
to be determined [21,25], it appears that 60% or less of Myc-
binding sites have a canonical E-box consensus motif.
Myc target-site recognition in the human genome is restricted
by epigenetic mechanisms, which act upstream of sequence-
specific DNA binding [25]. In particular, Myc preferentially
associates with promoters enriched for euchromatic marks,
including di- or tri-methylation of histone H3 lysines 4
(H3K4me2, H3K4me3) or lysine 79 (H3K79me2), as well as
acetylation of lysines 9 and 18 (H3K9ac, H3K18ac). Once bound
to its target promoters, Myc introduces further changes in
chromatin. In particular, Myc interacts with a variety of histone
modifiers, such as the HATs Tip60, GCN5/PCAF and p300/
CBP [26,27,28,29] or HAT-associated proteins such as TRRAP
[28,30] resulting in the recruitment of factors to chromatin and in
local hyper-acetylation of histones [26,27,31,32]. Consistent with
this molecular mechanism, Myc is required for histone hyper-
acetylation and transcriptional activation of target loci following
mitogenic stimulation of rodent fibroblasts [31]. In summary, Myc
targets already active or poised chromatin, inducing further
chromatin modifications and contributing to the fine-tuning of
gene expression in response to extra-cellular stimuli. However, the
range of chromatin modifications regulated by Myc on its target
loci remains unknown.
Results
Myc induces acetylation of several lysines on histone H3
and H4
The B-cell line P493-6 (or P493) expresses a Tetracycline (Tet)-
repressible c-myc transgene [33]. We previously used these cells to
profile Myc binding to E-box containing promoters by qChIP
analysis [18]. We also profiled histone marks in the absence of
Myc (+Tet) on two balanced populations of ‘‘Target’’ and ‘‘Non-
target’’ promoters (originally dubbed ‘‘high-’’ and ‘‘low-affinity’’,
respectively) [25]. Here, we use the same system to profile the
chromatin modifications induced by Myc: P493 cells were fixed
8 hours after Tetracyclin removal (2Tet), at which time Myc
binding to chromatin was maximal [18], chromatin was
immunoprecipitated with either of 27 antibodies, and the
recovered DNA was used to amplify 124 different promoter
sequences by real-time PCR. The recovery of each promoter
sequence in each ChIP (expressed as % of input chromatin) is
given in Supplementary Table S1. To account for nucleosomal
density at any given site, the qChIP values for histone marks were
then normalized to those of total histone H3. The resulting profiles
along all promoters are displayed in Figures 1, 2, 3, 4, 5, 6. We
also obtained qChIP profiles for two HATs (Tip60 and HBOI)
and for RNA Polymerase II (RNA PolII), shown in Figure 7. All
figures are organised as follows: the bar graph on the left reports
the enrichment at every promoter either without (+Tet: blue bars)
or with Myc (2Tet: red bars). Note that qChIP values are
expressed as % of input chromatin for non-histone proteins, while
histone marks or histone variants are normalized to total H3.
Promoters (#1–124) are ordered along the X-axis by increasing
Myc binding, shown in Fig. 1A, with full identification of all
promoters provided in Table S1. This display allows distinction of
Non-targets (#1–54) and Targets (#55–124), the two groups used
statistical analysis. The box plot on the right displays the fold-
change in qChIP value following Myc induction, averaged for the
two different promoter groups. This allows us to report two
fundamental parameters: first, whether each feature (Myc
enrichment; fold-change for every histone mark) shows a
significant change upon Myc induction within either promoter
group (p-values shown below the X-axis); second, whether the two
promoter groups are significantly distinct from one-another (p-
value above the X-axis). As an example, we have aligned Myc
binding with ‘‘pan’’ acetylation of histone H3 and H4: as
previously reported, these marks are selectively induced on Myc-
target genes [18,26] (Fig. 1B, C).
We then examined the acetylation state of specific lysines on
histones H4 and H3 (Fig. 2, 3). Myc most significantly enhanced
H3K14ac, H3K18ac, H3K9ac, H4K5ac and H4K12ac on its
Target promoters, followed by H4K8ac and H4K91ac. With the
exception of H3K14ac, which showed moderate induction also on
Non-target promoters (Fig. 3C), these marks were induced only in
the Target group: this is consistent with the notion that Myc
interacts with various HATs and recruits them to chromatin.
Other acetylation marks were not, or less significantly regulated by
Myc: H4K16 was modestly induced in both groups of promoters
(Fig. 2D), as well as at several other locations far from a TSS (data
not shown). H3K27ac was present selectively in the Target group
[25] but, with the exception of few promoters, was not modulated
by Myc. Of notice, in particular for H4, individual lysines did not
account for the more significant level of regulation observed with
the pan-acetyl antibody (Fig. 1B): indeed, individual marks were
not induced on all targets and showed different patterns across the
promoter population.
Myc induces incorporation of the histone variant H2A.Z
in target promoters
We previously identified histone H2A.Z as a component of
euchromatic promoters in P493 cells [25]. In yeast, H2A.Z
preferentially localizes in the two nucleosomes flanking the TSS
[34]. In human cells, H2A.Z preferentially occupies the 21
nucleosome and is evicted from chromatin upon transcriptional
activation [35], confirming the intrinsic instability observed in vitro
[36]. Upon Myc induction, H2A.Z was consistently up-regulated on
Target promoters, while no or little change was observed on non-
target promoters (Fig. 4A). We observed a similarly selective
increase in acetylatedH2A.Z (Fig. 4B:H2A.Zac includes acetyl-K4,
K7 and K11). Normalization of H2A.Zac to total H2A.Z showed
that acetylation was higher at Target genes, but was not modulated
by Myc itself (Fig. 4C). As a control, we also analysed total and K5-
acetylated H2A: unlike what observed for H2A.Z, Myc did not
induce H2A incorporation (Fig. 4D), although it enhanced its
acetylation on a subset of promoters in either group (Fig. 4E, F). We
conclude that Myc selectively induces H2A.Z incorporation in its
target promoters (probably at the 21 nucleosome) [35], but does so
without modifying its acetylation rate.
Analysis of histone H3 lysine methylation
We next sought to analyse changes in methylation of specific H3
lysines. Methylation of H3K9 or H3K27 is associated with
transcriptional repression and is generally low on Myc-target genes
[25]. Indeed, we did not observe any significant changes in mono-,
di- or tri-methylation of these residues upon Myc induction in
P493 cells (Fig. 5).
Di-methylation of H3K79 (H3K79me2) is associated with
transcriptional activity in human, fly and yeast cells [25,37,38],
and specifically with productive transcriptional elongation by PolII
[39]. Indeed, H3K79me2, but not H3K79me1, was up-regulated
selectively at a subset of target promoters (Fig. 6A, B).
Di- and trimethylation of H3K4 are associated with active or
poised promoters [3] and are present on Target promoters prior to
Myc binding [25]. Myc activation had no general effect on either
form of H3K4 methylation (me1, 2 or 3; Fig. 6C–E) although
Myc-Induced HMs
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cantly, in this context, Myc interacts with proteins regulating
either methylation or demethylation of H3K4 (see Discussion).
Chromatin modification patterns define different groups
of Myc targets
The data presented so far indicated that Myc modulates
acetylation and methylation marks to different extents, in different
combinations and on different subsets of target promoters. The
key question at this stage was whether these Myc-induced changes
might identify different groups (hereby, clusters) of target loci,
perhaps subject to different regulatory responses. To address this
question, the above qChIP data were subjected to an unbiased
clustering analysis, based on the variation (fold-change) of each
histone mark on each promoter upon Myc induction (Fig. 8A).
This was aligned with Myc binding levels at each locus (Fig. 8B),
the fold-changes in gene expression (Fig. 8C), as well as in binding
Tip60, HBOI and RNA PolII (Fig. 8D). Note that the parameters
in Fig. 8B–D were not used for the clustering analysis, which was
driven only by the changes in chromatin state: thus, their
enrichment in any given cluster reflects their independent
correlation with chromatin changes.
Based on this analysis, we identify two main clusters (I. and II.),
distinguished mainly through the opposite regulation of H2AK5,
H4K16ac, as well as H4K12ac (Fig. 8A, top 4 rows). As described
above, H2AK5, H4K16ac did not systematically distinguish
Target and Non-target promoters: logically, therefore, cluster I.
and II. contained promoters of both types (Fig. 8A, B). The
majority of Target and Non-target promoters segregated into two
sub-clusters within cluster I. (I.a and I.b). I.a contained mainly
Figure 1. Myc induces histone H3 and H4 hyper-acetylation. A. Myc levels in two E-box containing populations are analysed in P493-6 cell
line before (+Tet=blue bars) and after Myc induction (2Tet=red bars). B. Target sites display an upregulation of panacelylated histone H3 and (C)
panacelylated histone H4. The qChIP values are expressed as % of input and normalized for total histone H3 (B–C). (D) As in A–C, with he
immunoprecipitation performed with a no-antibody control. The box plots on the right show the fold change distribution for each modified residue
(B, C), or for Myc (A) in the two subpopulations (Non-targets and Targets). A two-sample t-test between the two subpopulations was performed and
the relative p-value calculated (value within each box plot). Two-sample paired t-test was performed between (+Tet) and (8h) samples, for the two
subpopulations and the p-value calculated (values at the bottom of each box plot).
doi:10.1371/journal.pone.0003650.g001
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marks (e.g. H4K16ac, H3K14ac, H2AK5ac and H4K91ac), but
no significant induction of the main Myc-responsive marks (e.g.
H3K9ac, H3K18ac, H2A.Z), no mRNA induction, and no
loading of Tip60, HBOI or RNA PolII. Sub-cluster I.b, instead,
contained promoters at which Myc consistently induced most, if
not all of the responsive marks (H3K9ac, H3K18ac, H3K14ac
H3K79me2, H4K12ac, H4K5ac, H4K8ac, H2AK5ac and
acetylated H2A.Z loading) (Fig. 8A). Most of these loci were
bound (Fig. 8B) and induced by Myc (Fig. 8C), and were those that
most consistently showed loading of Tip60, HBOI and RNA Pol2
(Fig. 7, 8D). Collectively, these features identify the changes
introduced by Myc on most of its direct target genes.
Othersub-clusters(I.c,II.a,II.b,II.c)contained smallergroups of
loci, with different combinations of Target/Non-target genes and
regulatory events, the significance of which remains to be
addressed. Also, as noted previously [25], a minority of the E
box-containing Target loci included in our study were repressed by
Figure 2. Myc regulates the levels of histone H4 acetylation. As in Fig 1. qChIP was performed using specific antibodies recognizing A.
H4K5ac, B. H4K8ac, C. H4K12ac D. H4K16ac E. H4K91ac.
doi:10.1371/journal.pone.0003650.g002
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small number of repressed genes covered, our data do not allow us
to identify histone modifications that uniquely characterize those
genes, and it remains to be addressed whether Myc can directly
participate in transcriptional repression via E-boxes. Our data are
consistent with the notion that Myc, when bound to this particular
consensus, participates mainly to transcriptional activation.
Discussion
Myc regulates multiple acetylation events
Through the use of quantitative ChIP, we have recorded the
changes induced by Myc in 25 histone marks on a representative
collection of E-box (CACGTG)-containing promoters in the
human B-cell line P493. Acetylation of several lysines (H3K9,
H3K18, H4K5, H4K8, H4K12, H3K14 and H2AK5) was up-
regulated at the majority of Myc-target promoters. The same
acetyl-lysines in H3/H4 (except H3K14ac) are part of a
‘‘backbone’’ of 17 marks associated with active promoters at a
genome-wide level in human T-cells [40] and, in yeast H4, have a
non-specific, cumulative role in transcriptional activation [11].
Consistent with these observations, Myc-enhanced acetylation
correlated with mRNA induction at the same target loci,
suggesting that these marks might collectively contribute to
transcriptional activation. Our data are also consistent with the
notion that Myc interacts with multiple HATs and recruits these
enzymes to its binding sites in chromatin, thereby enhancing
histone acetylation: we confirmed the recruitment of Tip60 [26]
and demonstrated that of the related enzyme HBO1, both of
which preferentially acetylate histone H4 [41]. Myc binds other
HATs, in particular GCN5/PCAF and p300/CBP
[27,28,29,42,43], which are likely to contribute to histone
acetylation at target promoters. The role of individual HATs in
Myc-induced transcription remains to be addressed: we foresee
that this will be significantly complicated by functional redundan-
cy, both among HATs and among the different acetylated lysines.
Figure 3. Myc regulates the levels of histone H3 acetylation. As in Fig 1. qChIP was performed using specific antibodies recognizing A.
H3K9ac, B. H3K18ac, C. H3K14ac D. H3K27ac.
doi:10.1371/journal.pone.0003650.g003
Myc-Induced HMs
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PLoS ONE | www.plosone.org 6 November 2008 | Volume 3 | Issue 11 | e3650In this context, it is noteworthy that there was also significant
heterogeneity in the exact combination of residues acetylated on
different target promoters (Fig. 2–4; 8).
Another acetylation mark, H3K27ac was present selectively in
the Target group but was not regulated by Myc. H3K27ac was
also one of the 17 marks associated with active promoters
throughout the genome [40], and is thus one of the euchromatic
features that characterize target genes prior to Myc binding [25].
Of the aforementioned marks, only H3K14ac was induced by
Myc also on Non-target promoters (Fig. 3C, 8), although less than
in the Target group, implying that Myc had an additional effect on
H3K14ac that did not depend upon direct DNA binding. Myc
also caused a moderate, general increase of H4K16ac on both
target and non-target promoters (Fig. 2D). This may be partly
explained by the findings that H3K14 and H4K16 can be
acetylated by GCN5 [44], and that GCN5 is encoded by a Myc-
target gene, induced in P493 cells [45] (unpublished data). It
should be noted, however, that GCN5 also targets H3K9 and
H3K18 [46,47], which were not acetylated at Non-target loci
upon Myc induction (Fig. 2, 3, 8). Unlike other H4 lysines, H4K16
has a non-redundant function in transcriptional activation in yeast
[11] and a unique role in counteracting compaction of the
chromatin fibre [48]. This type of general regulatory mechanism
may explain the role of Myc in maintaining bulk acetylation levels
and preventing chromatin compaction [45].
Myc induces incorporation of H2A.Z
Besides histone acetylation, Myc selectively induced incorpora-
tion of H2A.Z in its target promoters. Most interestingly, H2A.Z
was one of the features associated with active promoters at the
genome-wide level in human T-cells [40] and correlated with
selective loss of the nucleosome at the 21 position [35], most likely
required to accommodate the transcriptional apparatus at the
promoter [49]. Whether the 21 nucleosome is evicted from Myc-
target promoters and whether this occurs before or after Myc
induction remains to be addressed. At most of target loci, however,
RNA PolII appears to be loaded prior to Myc, although its levels
consistently increase [25,50] (Fig. 7C; see below).
The exchange of H2A.Z-H2B dimers is catalysed by the ATP-
dependent chromatin-remodelling enzymes Swr1 in yeast, and by
the homologous enzymes p400 or SRCAP in human cells
[51,52,53,54]. In yeast, the Swr1 complex shares several subunits
with the HAT complex NuA4. The catalytic subunit of NuA4 is
Esa1p, the yeast homologue of human Tip60 [55,56]. In higher
eukaryotes, the SWR1 and NuA4 complexes do not exist
separately but are instead merged into the Tip60 complex
[56,57], which includes Tip60 as the HAT and p400 as the
remodelling subunit [58,59]. In all systems investigated, acetyla-
tion of H4 or H2A isoforms by Esa1/Tip60 seems to be closely
connected with H2A.Z incorporation by Swr1/p400 [57,60,61].
Based on the observation that Myc recruited 5 subunits of the
Tip60 complex (Tip60, p400, TRRAP, Tip48 and Tip49) to target
promoters [26] we proposed that a similar mechanism may
operate in Myc-induced transcription [62]. The data reported
here lend further support to this model, by showing that
recruitment of the complex (as marked by Tip60) is accompanied
by incorporation of H2A.Z.
It should be noted here that a different hierarchical relationship
between Tip60, p400 and H2A.Z has been implicated in the
regulation of p53 target genes. At the p21 promoter, p53 was
required for localization of p400 and H2A.Z at its distal binding
sites prior to activation of the gene: upon activation of p53
signaling (by DNA damaging agents) p400 and H2A.Z were
evicted, which occurred before Tip60 recruitment and gene
activation [53]. Knockdown of either p400 or H2A.Z induced
transcription of the p21 gene, which was prevented by Tip60
knockdown [53,63,64]. These observations may owe to the
existence of p400 complexes that do not contain Tip60 [59],
although the form of Tip60 recruited without p400 still has to be
characterized. Altogether, it remains possible that Tip60 and p400
also exist in separate smaller complexes, as is the case in yeast.
Myc is also known to repress the p21 promoter via its
association with the transcription factor Miz-1, located at the
TSS [17,65]. Most interestingly, Myc induced enrichment of both
p400 and H2A.Z the p21 TSS [53], suggesting that these proteins
also mediate transcriptional repression by Myc.
A recent genome-wide study in P493 cells showed that a
significant fraction of Myc-target genes are repressed, which
includes genes bound via canonical E-boxes [20]. This warrants
further analysis of the mechanisms underlying repression by Myc
through the E-box, besides the INR/Miz1 site. Among the E box-
containing promoters in our collection, only a minority were
repressed by Myc [25] (Fig. 8): most likely owing to this under-
representation, our analysis of chromatin modifications has not led
to the identification of a distinct pattern associated with
transcriptional repression, and no definitive conclusions should
be drawn in this regard.
Effects of Myc on RNA PolII loading and elongation
Myc interacts with cyclin T1 and CDK9 (or pTEFb) and is
thereby thought to promote Serine 2 (S2) phosphorylation in the
PolII C-terminal domain (CTD) and transcription elongation [66].
Prior to S2, the CTD is phosphorylated on S5 by CDK7 (or
TFIIH), marking promoters that are active or poised for activation
[67,68]. The effects of Myc on S2 and S5 phosphorylation remain
to be systematically analysed by ChIP, and our efforts in this
regard have remained inconclusive. However, loading of RNA
PolII was clearly shown to precede Myc binding on multiple target
promoters and in different cell types [25,31,32,50,66] (Fig. 7C).
On several promoters targeted by both Myc and FoxO
transcription factors, loading of PolII and the basal transcription
machinery was Myc-independent, but instead required negative
control of FoxO by the PI3K pathway; Myc recruited both TFIIH
and pTEFb, thus controlling transcriptional elongation [50]. On
the same promoters, Myc also promoted histone acetylation
[31,32]. Altogether, the available data do not support the notion
that Myc regulates RNA PolII phsophorylation and histone
acetylation on two different categories of genes [66]. Instead, the
two mechanisms co-exist on the same promoters: most impor-
tantly, their functional relationship remains to be unravelled.
Effects of Myc on histone H3 lysine methylation
As opposed to Myc-induced acetylation, little was know about
potential effects of Myc on histone methylation. We have
Figure 4. Myc affects the incorporation levels of histone variant H2A.Z. As in Fig 1. qChIP was performed using specific antibodies
recognizing A. H2A.Z, B. H2A.Zac, D. H2A, E. H2AK5ac and G. H1. All the qChIP values are expressed as % of input and normalized for total histone
H3, with the exception of C and F, where H2A.Z acetylation is noramlized for H2A.Z density, and H2AK5 acetylation is normalized for H2A density,
respectively. The box plots show the fold change distribution of each acetylated residue for the two subpopulations. Statistical significance is
calculated as in Fig. 1.
doi:10.1371/journal.pone.0003650.g004
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PLoS ONE | www.plosone.org 7 November 2008 | Volume 3 | Issue 11 | e3650Figure 5. Myc does not alter the levels of heterochromatic marks. As in Fig 1. qChIP was performed using specific antibodies recognizing A–
C. H3K9me1-me2-me3 and D–F. H3K27me1-me2-me3.
doi:10.1371/journal.pone.0003650.g005
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by Myc on target promoters, concomitant with transcriptional
activation (Fig. 6A, 8). Methylation of H3K79, catalyzed by the
methyl-transferase Dot1L, has been associated with transcription
elongation [39,69]. Whether Myc directly regulates H3K79
methylation by recruiting Dot1L remains to be addressed,
although we failed to detect an interaction between those
proteins.
Figure 6. Myc regulates histone methylation in a promoter specific manner. As in Fig. 1, qChIP was performed using specific antibodies
recognizing A. H3K79me2, B. H3K79me1, C. H3K4me1, D. H3K4me2 and E. H3K4me3.
doi:10.1371/journal.pone.0003650.g006
Myc-Induced HMs
PLoS ONE | www.plosone.org 9 November 2008 | Volume 3 | Issue 11 | e3650H3K4me2 and H3K4me3 mark transcriptionally active or
poised promoters [3] and are a characteristic feature of Myc-target
chromatin prior to– and independently from Myc binding [25].
Myc had no general effect on these methylation marks, although it
did cause their up- or down-regulation on individual promoters
(Fig. 6D, E). Significantly, in this context, Myc interacts with
proteins regulating either methylation or demethylation of H3K4.
First, Myc binds JARID-family demethylases [70] (our unpublished
results). This interaction has been proposed to antagonize the
demethylaseactivityofLID,theJARID1a-dhomologinDrosophila
[70]. Second, Myc interacts with H3K4 methyl-transferases
complexesoftheMLLfamily(B.Lu ¨scher,personalcommunication;
our unpublished results). This association might serve a dual role.
First, it may help targeting Myc to the appropriate chromatin
environment, whichprecedessequence-specific DNAbinding.Such
a mechanism is important for target gene recognition by Myc [25],
as well as FoxA1 [71]. Second, Myc may contribute to recruit and/
or stabilize MLL complexes at certain promoters.
Altogether, given the pre-existence of H3K4me3 and its
independence upon Myc [25], the recruitment of either MLL- or
JARID-family proteins is unlikely to be a general mechanism in
Myc-regulated transcription, but might be relevant on promoters at
which Myc up- or down-modulates H3K4me3. While there is
clearly no obligate link between transcriptional activation by Myc
and up-regulation of H3K4me3 (Fig. 8), the possible role of H3K4
de-methylation in repression remains to be addressed. We finally
note that on/off and off/on transitions in Myc expression (either as
achieved here with Tet-mediated regulation or in other instances
with serum deprivation/stimulation) are adequate to study dynamic
chromatin regulation by Myc, but will most likely miss its effects in
epigenetic reprogramming. Besides being a potent oncogene,Mycis
one of four factors that, when co-expressed, contributes to
reprogram somatic cells to a pluripotent state [72,73,74]. Other
studies have associated Myc with self-renewal of Embryonic Stem
(ES) cells [75] and with the induction of an ES-like gene expression
profile is a variety of cells and tumors [76]. These findings warrant
further studies on the control of histone methylation by Myc during
cellular transformation and reprogramming.
Methods
Cell culture
P493-6 cells were grown in suspension in RPMI supplemented
with 10% foetal calf serum (FCS), NEAA (BioWhittaker), L-
glutammine and antibiotics. For ChIP, 2 L of logarithmically
growing cells were split to 3610
5 cells/ml, and 0.1 mg/ml
tetracycline (Sigma) was added for 72 h. To reinduced expression
of Myc, cells were washed three times with PBS and then cultured for
8 h (RPMI).
Antibodies
The antibodies used for ChIP were the following. From Santa
Cruz: c-Myc (sc-764), PolII (sc-899). From AbCam: ab18255
H2A; ab18262 H2A.Zac; ab7789 H1; ab1764 H2AK5ac; ab4174
Figure 7. Analysis of Tip60, HBO1 and RNA PolII recruitment. As in Fig. 1, qChIP was performed using specific antibodies recognizing A.
Tip60, B. HBO1, C. total RNA PolII.
doi:10.1371/journal.pone.0003650.g007
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ab3594 H3K79me2; ab8895 H3K4me1; ab2886 H3K79me1;
ab7312 H3K9me2; ab8580 H3K4me3; ab1791 H3; ab1761
H4K12ac; ab1762 H4K16ac; ab1758 H4K5ac; ab1760 H4K8ac;
ab4627 H4K91ac. From Upstate: 06-866 H4pan-ac; 06-599
H3pan-ac; 07-327 H4K5ac; 07-328 H4K8ac; 07-323 H4K12ac;
07-329 H4K16ac; 07-360 H3K27ac; 07-354 H3K18ac; 07-353
H3K14ac; 07-473 H3K4me3. H3K9me1, me2, me3 and
H3K27me1, me2, me3 were kindly provided by T. Jenuwein
[77]. Anti-Tip60 rabbit polyclonals have been previously described
[26,78]. The anti-HBO1 polyclonal has been raised immunizing
rabbits with a C-terminal peptide of human HBO1.
Quantitative Chromatin Immunoprecipitation (qChIP)
P493-6 cells were processed for qChIP following our original
protocol with further modifications. Formaldehyde (37%) was
Figure 8. Clustering analysis of histone marks changes on human promoters. A. Quantitative chromatin immunoprecipitation (qChIP) was
performed using 27 antibodies indicated on the right, plus a no-antibody control. The immunoprecipitations were performed with chromatin from
p493 cells in the absence of Myc (+tetracycline, Tet), and 8 hours after Myc induction (2Tet). For this clustering analysis, the qChIP values for all
histone marks on 124 promoters were normalized to those of total histone H3 and expressed as fold change values. B. Histogram representing Myc
binding levels, reported as % of input. C. The expression level of each gene is represented as fold change upon Myc induction. D. qChIP was
performed against Tip60, HBO1 and total RNA PolII. The ordering of the amplicons in B–D is based on the cluster analysis in A. The green and orange
labels associated to each promoter indicate whether this is classified as Target (high-affinity) or Non-target (low-affinity) in this study.
doi:10.1371/journal.pone.0003650.g008
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Cross-linking was allowed to continue for 10 min at room
temperature and stopped by addition of glycine (0,125 M as final
concentration), followed by an additional incubation of 5 min.
Fixed cells were washed twice with PBS and harvested in SDS
buffer (50 mM Tris at pH 8.1, 0,5% SDS, 100 mM NaCl, 5 mM
EDTA, and protease inhibitors). Cells were pelleted by centrifu-
gation, and resuspended in 3 ml of IP buffer (100 mM Tris at
pH 8.6, 0.3% SDS, 1.7% Triton X-100, and 5 mM EDTA). Cells
were disrupted by 5–7 pulses (30 sec each one) of sonication with a
tapered J-microtip (6,5 mm) in a Branson digital sonifier 250 D,
at a power setting of 30%, yielding genomic DNA fragments with
a bulk size of 300–500 bp. For each immunoprecipitation, 1 ml of
diluted lysate (5610
7 cells/ml) was precleared by addition of
300 ml blocked protein A or G beads (50% slurry protein A-
Sepharose from Amersham or Rec-protein G-Sepharose 4B
ZYMED from invitrogen; 0.5 mg/ml fatty acid free BSA, Sigma;
and 0.2 mg/ml salmon sperm DNA in TE). Samples were
immunoprecipitated overnight at 4uC with antibodies specific for
factors or modified histones. Immune complexes were recovered
by adding 50 ml of bloked beads and incubated for 2 h at 4uC.
Beads were washed and crosslink was reversed in 1% SDS and
0.1 M NaHCO3. The eluted material was purified with QIAquick
PCR purification Kit, Qiagen. The obtained DNA was resus-
pended in 1ml of T buffer (Tris HCl 10 mM pH 8) and used
directly for qPCR.
Quantitative PCR
Real-time PCR was performed with 6 mL of DNA per reaction
and 200 nM primers, diluted in a final volume of 20 mL in SYBR
Green Reaction Mix (Perkin Elmer, Boston, MA). Accumulation
of fluorescent products was monitored by real-time PCR using a
GeneAmp 9700 Sequence Detector (ABI). Each PCR reaction
generated only the expected specific amplicon, as shown by the
melting-temperature profiles of final products (dissociation curve,
automatically measured by the Taqman 9700). No PCR products
were observed in the absence of template. PCR primer sequences
are given in Supplementary Information (Table S1).
Bioinformatic analysis
Data analysis was performed using R 2.6.0 and GeneSpring GX
7.3.1 (Agilent Technologies). For the clustering of Figure 8 and the
boxplots of Figures 1–6 DNA recovery values (percentage of input
DNA) for each histone ChIP were normalized to those of total H3
for the 124 sites analysed. A threshold for low raw values was
applied (0.39 for histone marks, 0.032 for transcription factors/co-
factors; the threshold were calculated based on the highest values
of the control/negative ChIPs), and fold change between 2Tet/
+Tet was calculated. Hierarchical clustering was generated by
computing distance based on Sperman’s rank (GeneSpring
implemented algorithm) and using an average linkage method.
Fold change was log transformed and boxplots were created using
R. Two-sample t-test between Myc-targets and non-targets was
performed and the relative p-value calculated. Two-sample paired
t-test was performed between (+Tet) and (2Tet) samples and the
p-value calculated.
Supporting Information
Table S1 Genomic coordinates, PCR primers and qChIP data.
The columns are defined by the following headings: Amplicon#:
Each PCR amplicons is identified by the reference number of its 59
primer in our laboratory database. X-axis Fig. 1–6: Numbering of
each locus/amplicon on the X-axis of all bar-graphs in figures 1–6.
These numbers correspond to increasing Myc binding, determined
by the qChIP values in column Myc (2tet). Order Fig. 8: The
number indicated the order of appearance of each locus in the
clustering analysis of Fig. 8. Chr, Start, End: chromosomal
coordinates of each PCR amplicon. Forward, Reverse: sequences
of the corresponding PCR primers. Amplicon Seq, Length:
sequence and length of each amplicon. Gene: name of the gene.
For bi-directional promoters, the two genes are named. mRNA:
Variation in mRNA levels for each gene. For bi-directional
promoters, the data refer to the first gene listed. Data are
represented as the ratio of mRNA levels in the two experimental
conditions (2/+tet) normalized to 18S levels. ND: mRNA not
detected (in either 2tet or +tet). na: mRNA not addressed. All
other columns: The numbers show qChIP data (expressed as % of
input chromatin) for each protein or histone mark analyzed
(indicated in the heading) with or without tetracylin (+tet, 2tet).
Found at: doi:10.1371/journal.pone.0003650.s001 (0.27 MB
RTF)
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